CAPN3 Gene: Calpain 3

Key regulator of muscle structure and function; mutations cause limb-girdle muscular dystrophy type 2A (LGMD2A)

Gene Information Card

Symbol CAPN3
Full Name calpain 3
Gene Type protein-coding
Chromosomal Location 15q15.1
NCBI Gene ID 825 ncbi.nlm.nih.gov/gene/825
Ensembl ID ENSG00000142319
UniProt ID P20807
OMIM ID 114240
HGNC ID 1479
Aliases CANP3, LGMD2A, nCL-1, p94

Description

The CAPN3 gene encodes calpain 3, a muscle-specific calcium-dependent cysteine protease. It is a member of the calpain family and plays a critical role in sarcomere remodeling, myofibril stability, and muscle cell survival. Mutations in CAPN3 are the primary cause of limb-girdle muscular dystrophy type 2A (LGMD2A), also known as calpainopathy. The protein undergoes rapid autolysis and is localized to the titin N2A region, where it regulates proteolysis and signaling pathways essential for muscle maintenance.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Limb-girdle muscular dystrophy type 2A (LGMD2A) Loss-of-function mutations in CAPN3 impair calpain 3 proteolytic activity, leading to defective sarcomere remodeling, increased apoptosis, and progressive muscle fiber degeneration. ClinVar, OMIM
Muscular dystrophy, limb-girdle, autosomal recessive 1 (LGMDR1) Same as LGMD2A; biallelic pathogenic variants cause recessive calpainopathy. ClinVar, OMIM
Sporadic inclusion body myositis (sIBM) Reduced CAPN3 expression and altered autolytic activity observed in muscle biopsies; potential role in protein aggregation. NCBI Gene, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle 78.5 High
Heart 2.3 Low
Brain 0.4 Not detected
Liver 0.1 Not detected
Kidney 0.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
Skeletal muscle myotubes 85.2 Differentiated primary cells
Rhabdomyosarcoma (RD) 12.4 Cancer cell line
Fibroblasts (normal) 0.3 Low expression
HEK293 0.1 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.550delA Frameshift Common in European populations Loss of function
c.598_612del In-frame deletion Rare Loss of function
c.2362AG>TCATCT Missense Found in LGMD2A families Loss of function
c.1746-20C>G Splice site Pathogenic Loss of function
Mutation functional classification

Loss of Function (LOF)

Most CAPN3 mutations are recessive loss-of-function, leading to absent or severely reduced proteolytic activity and LGMD2A.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in CAPN3.

Dominant Negative (DN)

Rare dominant-negative effects have been suggested in some missense variants, but evidence is limited; primarily recessive.

Pathways

Calpain proteolysis pathway (Reactome: R-HSA-5625740)
Muscle contraction (Reactome: R-HSA-397014)
Titin/calpain signaling (Reactome: R-HSA-390522)

Protein Summary

Calpain 3 (p94) is a 94 kDa muscle-specific protease that contains four domains: a catalytic cysteine protease domain (CysPc), a calpain-type beta-sandwich domain (CBSW), and two C-terminal EF-hand domains. It binds to titin at the N2A region and undergoes rapid autolysis. The protein is essential for sarcomere integrity, myofibril turnover, and protection against apoptosis. Loss of calpain 3 activity leads to progressive muscle weakness and dystrophy.

Related Products

Product name Cat.No. Species Gene ID
CAPN3 Knockout HEK293 Cell Line EDJ-KQ3508 Human 825 Details Get a Quote
CAPN3 Knockout A-549 Cell Line EDJ-KQ26641 Human 825 Details Get a Quote
CAPN3 Knockout HCT 116 Cell Line EDJ-KQ26643 Human 825 Details Get a Quote
CAPN3 Knockout HeLa Cell Line EDJ-KQ26644 Human 825 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: